Molecular Mechanisms of Exerkines in Heart Failure: Linking Exercise to Clinical Outcomes
Overview
Exercise training in heart failure patients significantly reduces proinflammatory cytokines IL-6 and TNF-α, correlating with improved cardiac function and exercise capacity. These findings highlight exerkines as key molecular mediators bridging exercise-induced biological adaptations and clinical benefits.
Background
Heart failure is characterized by impaired exercise capacity due to cardiac dysfunction and systemic abnormalities such as skeletal muscle atrophy and chronic inflammation. Exercise training activates multiple signaling pathways that protect the myocardium and promote systemic adaptations. Exerkines, molecules released during exercise from tissues like skeletal muscle and heart, mediate these beneficial effects and represent promising therapeutic targets. Understanding their role can enhance personalized rehabilitation strategies in heart failure.
Data Highlights
Parameter
Effect of Exercise Training
Interleukin-6 (IL-6)
Significant reduction
Tumor Necrosis Factor-alpha (TNF-α)
Significant reduction
Lactate
No significant change
Correlation with VO₂ max and LVEF
Greater cytokine reductions associated with larger improvements
Key Findings
Structured physical training significantly lowers circulating IL-6 and TNF-α levels in heart failure patients.
Reduction in these proinflammatory cytokines correlates with improved maximal oxygen consumption (VO₂ max) and left ventricular ejection fraction (LVEF).
No significant changes were observed in lactate levels following exercise training.
The molecular benefits of exercise appear more pronounced in patients with reduced ejection fraction.
Exerkines serve as dynamic biomarkers reflecting biological adaptations during rehabilitation and may guide personalized exercise prescriptions.
Current evidence is limited by study populations predominantly from high-income countries, highlighting the need for broader demographic inclusion.
Clinical Implications
Exercise should be integrated as a fundamental component of heart failure management, not only to improve functional capacity but also to modulate inflammatory and metabolic pathways. Monitoring exerkine levels may help personalize rehabilitation programs, identify responders, and optimize exercise intensity and volume for maximal benefit. Future clinical protocols should consider molecular biomarkers alongside traditional functional assessments.
Conclusion
Physical exercise reduces proinflammatory exerkines in heart failure, linking molecular adaptations to improved clinical outcomes. These insights position exerkines as promising biomarkers and therapeutic targets to enhance personalized rehabilitation strategies.
